Gelteq Limited Ordinary Shares (GELS)

Gelteq Limited Ordinary Shares (GELS) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.9M; returns 1 day -1.1%, 1 week -3.5%, 1 year -69.0%.

Gelteq Limited is a clinical-stage biotechnology company specializing in the development of a proprietary ingestible gel-based delivery platform designed to enhance the bioavailability and palatability of active pharmaceutical ingredients (APIs), nutraceuticals, and veterinary medications.

Groups GELS belongs to

• Clinical Stage Biotech
• Biotechnology
• Healthcare
• Dietary Supplements
• Metabolic Disorders
• Health and Wellness Products
• Contract Manufacturing

GELS financial model: income statement, cash flow and balance sheet